original articlesgastrointestinal cancerComorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
gastrointestinal cancer
Under an Elsevier user license
open archive
Keywords
advanced colorectal cancer
age
cetuximab
Charlson comorbidity score
comorbidity
Cited by (0)
Copyright © 2010 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.